Endosonographic Shear Wave Elastography for Liver Stiffness

NCT04533932 — Unknown, 40 participants, Midwest Biomedical Research

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Endosonographic Real-time and Shear Wave Elastography to Assess Liver stiffness-a Pilot Study

RegistryNCT04533932
StatusUnknown
Study typeObservational
Enrollment40 (Estimated)
SponsorMidwest Biomedical Research (Other); collaborators: Olympus Corporation of the Americas
ConditionsLiver Cirrhosis
InterventionsElastography (Diagnostic test)
Datesstart 2020-09-08, primary completion 2021-08-01 (estimated), completion 2021-08-01 (estimated), first posted 2020-09-01, last updated 2021-02-23
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Liver Cirrhosis All trials of Elastography

-Summary

This is a single-center, prospective, non-randomized, comparative study which will compare the diagnostic accuracy and safety of endosonographic real-time Elastography and shear wave Elastography with the current standards of care, i.e. liver biopsy and Vibration-controlled transient elastography (Fibroscan). Subjects who are referred for an endoscopic ultrasound (EUS) guided liver biopsy will be prospectively enrolled to undergo liver biopsy, Elastography and/or Vibration-controlled transient elastography.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
ElastographyDiagnostic Test: Elastography
  • Elastography (Diagnostic test): Endosonographic shear wave elastography

+Outcome measures

Primary outcomes

  • Degree of fibrosis [through study completion, an average of 1 year]: Degree of fibrosis based on histological assessment

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients referred for EUS guided liver biopsy
* Elevated liver enzymes without obvious etiology, thus necessitating liver biopsy or clinical concern for cirrhosis or NASH requiring histological confirmation
* Ability to provide informed consent and willing to participate

Exclusion Criteria:

* Clinical evidence of cirrhosis which obviates need for liver biopsy
* Noninvasive lab testing which confirms presence of cirrhosis
* Surgically altered foregut anatomy which precludes safe endoscopic liver biopsy
* Coagulopathy with INR greater than 1.6 in patients on anticoagulant therapy
* Thrombocytopenia with platelet count less than 50,000/mL
* Pregnancy (positive urine pregnancy test in females of childbearing age)
* Lack of consent

+Locations (1)

FacilityCityCountryStatus
Kansas City VA Medical CenterKansas City, MissouriUnited StatesRecruiting

+Publications

  • Results publication: Kohli DR, Mettman D, Andraws N, Haer E, Porter J, Ulusurac O, Ullery S, Desai M, Siddiqui MS, Sharma P. Comparative accuracy of endosonographic shear wave elastography and transcutaneous liver stiffness measurement: a pilot study. Gastrointest Endosc. 2023 Jan;97(1):35-41.e1. doi: 10.1016/j.gie.2022.08.035. Epub 2022 Aug 29. PMID 36049537